DNS vs Thoracic Stabilization Exercises in Thoracic Kyphosis (NCT07255794) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
DNS vs Thoracic Stabilization Exercises in Thoracic Kyphosis
Turkey (Türkiye)30 participantsStarted 2025-12-01
Plain-language summary
This randomized controlled trial aims to compare the effects of Dynamic Neuromuscular Stabilization (DNS) exercises and thoracic stabilization exercises on thoracic erector spinae muscle strength, thoracic kyphosis angle, pain and trunk stabilization in individuals with thoracic kyphosis. Thirty participants aged 18-40 years with thoracic kyphosis will be randomly allocated to a DNS exercise group or a thoracic stabilization exercise group. Surface EMG biofeedback will be used to assess thoracic erector spinae muscle activation, while pain, thoracic kyphosis angle and trunk endurance will be evaluated using validated clinical tests. The interventions will be applied for 6 weeks, and outcomes will be assessed before and after the intervention period.
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 18 and 40 years.
* Presence of thoracic kyphosis based on clinical and flexible ruler assessment.
* Able to perform exercise-based interventions.
* Voluntarily agrees to participate and signs the informed consent form.
* No neurological, systemic, cardiac or orthopedic condition that would prevent safe participation in the exercise program.
Exclusion Criteria:
* Age outside the range of 18-40 years.
* Pregnancy.
* Malignancy.
* History of spinal surgery within the last year.
* Currently performing spinal or intensive core stabilization exercises.
* Visual, auditory or cognitive impairment that would interfere with cooperation during the intervention.
* Contraindications to exercise participation.
* Non-adherence to the exercise program (not performing exercises for three consecutive days).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Thoracic Kyphosis Index (Flexible Ruler Measurement)